- Home
- TLIS
as 07-26-2024 4:00pm EST
Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care. Its Talis One System is a molecular diagnostic platform developed to enable point-of-care testing for infectious diseases such as COVID-19.
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | REDWOOD CITY |
| Market Cap: | 15.9M | IPO Year: | 2021 |
| Target Price: | $5.00 | AVG Volume (30 days): | 5.7K |
| Analyst Decision: | Strong Sell | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -31.43 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.35 - $9.60 | Next Earning Date: | 08-08-2024 |
| Revenue: | $989,000 | Revenue Growth: | -65.21% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Talis Biomedical Corporation News
TLIS Breaking Stock News: Dive into TLIS Ticker-Specific Updates for Smart Investing
Journal-News, Hamilton, Ohio
2 months ago
Retiring ODW executive to be first inductee in Hamilton Business Hall of Fame
Motley Fool
2 months ago
Once-in-a-Generation Investment Opportunity: Why You Should Buy Carnival Stock Now
TechCrunch
2 months ago
Cat-sitting startup Meowtel clawed its way to profitability despite trouble raising from dog-focused VCs
The Telegraph
2 months ago
Italian energy company targets Britain for fleet of 20 mini-nukes
Simply Wall St.
2 months ago
It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend
Bloomberg
2 months ago
Saudis Said to Hand About 60% of Aramco Offer to Foreigners
Simply Wall St.
2 months ago
Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?
Simply Wall St.
2 months ago
Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks
Compare TLIS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TLIS Talis Biomedical Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.